Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.

Bhagwate AV, Liu Y, Winham SJ, McDonough SJ, Stallings-Mann ML, Heinzen EP, Davila JI, Vierkant RA, Hoskin TL, Frost M, Carter JM, Radisky DC, Cunningham JM, Degnim AC, Wang C.

BMC Genomics. 2019 Sep 2;20(1):689. doi: 10.1186/s12864-019-6056-8.

2.

Mastectomy and immediate breast reconstruction in the elderly: Trends and outcomes.

Sada A, Day CN, Hoskin TL, Degnim AC, Habermann EB, Hieken TJ.

Surgery. 2019 Oct;166(4):709-714. doi: 10.1016/j.surg.2019.05.055. Epub 2019 Aug 5.

PMID:
31395398
3.

Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their Forties.

Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC.

Ann Surg Oncol. 2019 Nov;26(12):3920-3930. doi: 10.1245/s10434-019-07653-9. Epub 2019 Aug 2.

PMID:
31376035
4.

Outcomes of > 1300 Nipple-Sparing Mastectomies with Immediate Reconstruction: The Impact of Expanding Indications on Complications.

Young WA, Degnim AC, Hoskin TL, Jakub JW, Nguyen MD, Tran NV, Harless CA, Manrique OJ, Boughey JC, Hieken TJ.

Ann Surg Oncol. 2019 Oct;26(10):3115-3123. doi: 10.1245/s10434-019-07560-z. Epub 2019 Jul 24.

PMID:
31342370
5.

Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis.

Kupstas AR, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2019 Oct;26(10):3240-3249. doi: 10.1245/s10434-019-07566-7. Epub 2019 Jul 22.

PMID:
31332635
6.

Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation.

Lee HE, Arshad M, Brahmbhatt RD, Hoskin TL, Winham SJ, Frost MH, Radisky DC, Denison LA, Degnim AC, Visscher DW.

Mod Pathol. 2019 Sep;32(9):1263-1270. doi: 10.1038/s41379-019-0217-9. Epub 2019 Apr 17.

PMID:
30996252
7.

ASO Author Reflections: A Statistical Caution Regarding Missing Clinical Stage in the National Cancer Database.

Hoskin TL, Boughey JC.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):569-570. doi: 10.1245/s10434-019-07195-0. Epub 2019 Jan 31. No abstract available.

PMID:
30706230
8.

Lessons Learned Regarding Missing Clinical Stage in the National Cancer Database.

Hoskin TL, Boughey JC, Day CN, Habermann EB.

Ann Surg Oncol. 2019 Mar;26(3):739-745. doi: 10.1245/s10434-018-07128-3. Epub 2019 Jan 4.

PMID:
30610561
9.

Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.

Barron AU, Hoskin TL, Day CN, Hwang ES, Kuerer HM, Boughey JC.

JAMA Surg. 2018 Dec 1;153(12):1120-1126. doi: 10.1001/jamasurg.2018.2696.

10.

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC.

Ann Surg Oncol. 2018 Sep;25(9):2596-2602. doi: 10.1245/s10434-018-6637-9. Epub 2018 Jul 5.

PMID:
29978369
11.

Effect of Primary Breast Tumor Location on Axillary Nodal Positivity.

Desai AA, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):3011-3018. doi: 10.1245/s10434-018-6590-7. Epub 2018 Jul 2.

PMID:
29968027
12.

Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.

Barron AU, Hoskin TL, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2867-2874. doi: 10.1245/s10434-018-6578-3. Epub 2018 Jun 28.

PMID:
29956095
13.

Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.

Desai AA, Jimenez RE, Hoskin TL, Day CN, Boughey JC, Hieken TJ.

Ann Surg Oncol. 2018 Oct;25(10):3064-3068. doi: 10.1245/s10434-018-6591-6. Epub 2018 Jun 26.

PMID:
29947004
14.

Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes.

Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Aug;25(8):2241-2248. doi: 10.1245/s10434-018-6531-5. Epub 2018 May 21.

PMID:
29786125
15.

Management of the axilla in metaplastic breast carcinoma.

Murphy BL, Fazzio RT, Hoskin TL, Glazebrook KN, Keeney MG, Habermann EB, Hieken TJ.

Gland Surg. 2018 Apr;7(2):200-206. doi: 10.21037/gs.2018.01.01.

16.

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.

Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC.

J Clin Oncol. 2018 Jun 20;36(18):1840-1846. doi: 10.1200/JCO.2017.75.9480. Epub 2018 Apr 20.

17.

Longitudinal stability of fibromyalgia symptom clusters.

Hoskin TL, Whipple MO, Nanda S, Vincent A.

Arthritis Res Ther. 2018 Feb 27;20(1):37. doi: 10.1186/s13075-018-1532-0.

18.

Impact of Neoadjuvant Chemotherapy on Nodal Disease and Nodal Surgery by Tumor Subtype.

Al-Hilli Z, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Feb;25(2):482-493. doi: 10.1245/s10434-017-6263-y. Epub 2017 Nov 27.

PMID:
29181679
19.

Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease.

Carter JM, Hoskin TL, Pena MA, Brahmbhatt R, Winham SJ, Frost MH, Stallings-Mann M, Radisky DC, Knutson KL, Visscher DW, Degnim AC.

Cancer Prev Res (Phila). 2018 Feb;11(2):113-119. doi: 10.1158/1940-6207.CAPR-17-0245. Epub 2017 Nov 22.

20.

CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.

Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, Murphy L, Denison L, Carter JM, Knutson KL, Degnim AC.

Breast Cancer Res Treat. 2018 Feb;167(3):649-658. doi: 10.1007/s10549-017-4558-0. Epub 2017 Nov 1.

21.

Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.

Hieken TJ, Murphy BL, Boughey JC, Degnim AC, Glazebrook KN, Hoskin TL.

Clin Breast Cancer. 2018 Aug;18(4):e501-e506. doi: 10.1016/j.clbc.2017.10.003. Epub 2017 Oct 7.

PMID:
29089281
22.
23.

Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study.

Peethambaram PP, Hoskin TL, Day CN, Goetz MP, Habermann EB, Boughey JC.

NPJ Breast Cancer. 2017 Oct 19;3:41. doi: 10.1038/s41523-017-0044-4. eCollection 2017.

24.

Flat Epithelial Atypia on Core Biopsy and Upgrade to Cancer: a Systematic Review and Meta-Analysis.

Rudin AV, Hoskin TL, Fahy A, Farrell AM, Nassar A, Ghosh K, Degnim AC.

Ann Surg Oncol. 2017 Nov;24(12):3549-3558. doi: 10.1245/s10434-017-6059-0. Epub 2017 Aug 22. Review.

PMID:
28831724
25.

NanoString-based breast cancer risk prediction for women with sclerosing adenosis.

Winham SJ, Mehner C, Heinzen EP, Broderick BT, Stallings-Mann M, Nassar A, Vierkant RA, Hoskin TL, Frank RD, Wang C, Denison LA, Vachon CM, Frost MH, Hartmann LC, Aubrey Thompson E, Sherman ME, Visscher DW, Degnim AC, Radisky DC.

Breast Cancer Res Treat. 2017 Nov;166(2):641-650. doi: 10.1007/s10549-017-4441-z. Epub 2017 Aug 10.

26.

Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.

Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):2972-2980. doi: 10.1245/s10434-017-5960-x. Epub 2017 Aug 1.

27.

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.

Welsh JL, Hoskin TL, Day CN, Thomas AS, Cogswell JA, Couch FJ, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):3067-3072. doi: 10.1245/s10434-017-5959-3. Epub 2017 Aug 1.

28.

Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study.

Nguyen TT, Hoskin TL, Day CN, Habermann EB, Goetz MP, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):2989-2998. doi: 10.1245/s10434-017-5930-3. Epub 2017 Aug 1.

PMID:
28766214
29.

Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.

Welsh JL, Hoskin TL, Day CN, Habermann EB, Goetz MP, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):2881-2888. doi: 10.1245/s10434-017-5932-1. Epub 2017 Aug 1.

PMID:
28766197
30.

Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution.

Stallings-Mann ML, Heinzen EP, Vierkant RA, Winham SJ, Hoskin TL, Denison LA, Nassar A, Hartmann LC, Visscher DW, Frost MH, Sherman ME, Degnim AC, Radisky DC.

Breast Cancer Res Treat. 2017 Nov;166(1):133-143. doi: 10.1007/s10549-017-4413-3. Epub 2017 Jul 27.

31.

Is axillary surgery beneficial for patients with adenoid cystic carcinoma of the breast?

Welsh JL, Keeney MG, Hoskin TL, Glazebrook KN, Boughey JC, Shah SS, Hieken TJ.

J Surg Oncol. 2017 Nov;116(6):690-695. doi: 10.1002/jso.24702. Epub 2017 Jun 12.

PMID:
28608456
32.

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.

Peña A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC.

Breast Cancer Res Treat. 2017 Jul;164(2):295-304. doi: 10.1007/s10549-017-4253-1. Epub 2017 May 4. Review.

PMID:
28474262
33.

Mastectomy and Immediate Breast Reconstruction for Cancer in the Elderly: A National Cancer Data Base Study.

Gibreel WO, Day CN, Hoskin TL, Boughey JC, Habermann EB, Hieken TJ.

J Am Coll Surg. 2017 May;224(5):895-905. doi: 10.1016/j.jamcollsurg.2016.12.051. Epub 2017 Feb 23.

PMID:
28238934
34.

Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.

Degnim AC, Hoskin TL, Arshad M, Frost MH, Winham SJ, Brahmbhatt RA, Pena A, Carter JM, Stallings-Mann ML, Murphy LM, Miller EE, Denison LA, Vachon CM, Knutson KL, Radisky DC, Visscher DW.

Clin Cancer Res. 2017 Jul 15;23(14):3945-3952. doi: 10.1158/1078-0432.CCR-16-2026. Epub 2017 Jan 26.

35.

Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?

Boughey JC, Haffty BG, Habermann EB, Hoskin TL, Goetz MP.

Ann Surg Oncol. 2017 Mar;24(3):614-617. doi: 10.1245/s10434-016-5740-z. Epub 2017 Jan 4. No abstract available.

PMID:
28054190
36.

National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.

Puig CA, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2017 May;24(5):1242-1250. doi: 10.1245/s10434-016-5733-y. Epub 2016 Dec 20.

PMID:
28000076
37.

Outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer Patients.

Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Jakub JW, Krajewski AC, Jacobson SR, Hieken TJ.

Am J Surg. 2017 Apr;213(4):810-813. doi: 10.1016/j.amjsurg.2016.07.031. Epub 2016 Sep 3.

PMID:
27692794
38.

Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study.

Chiba A, Hoskin TL, Heins CN, Hunt KK, Habermann EB, Boughey JC.

Ann Surg Oncol. 2017 Feb;24(2):418-424. doi: 10.1245/s10434-016-5585-5. Epub 2016 Sep 23.

39.

Contemporary operative management of T4 breast cancer.

Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Carter JM, Glazebrook KN, Hieken TJ.

Surgery. 2016 Oct;160(4):1059-1069. doi: 10.1016/j.surg.2016.06.030. Epub 2016 Aug 9.

PMID:
27521042
40.

The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease.

Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, Yao JZ, Baddour LM, Chia N, Degnim AC.

Sci Rep. 2016 Aug 3;6:30751. doi: 10.1038/srep30751.

41.

Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.

Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Glazebrook KN, Hieken TJ.

Ann Surg Oncol. 2016 Oct;23(10):3365-70. doi: 10.1245/s10434-016-5367-0. Epub 2016 Jun 30.

PMID:
27364506
42.

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.

Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW.

Cancer. 2016 Oct;122(19):2971-8. doi: 10.1002/cncr.30153. Epub 2016 Jun 28.

43.

Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.

Chiba A, Hoskin TL, Hallberg EJ, Cogswell JA, Heins CN, Couch FJ, Boughey JC.

Ann Surg Oncol. 2016 Oct;23(10):3232-8. doi: 10.1245/s10434-016-5328-7. Epub 2016 Jun 23.

44.

Validation of the CPS + EG Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Abdelsattar JM, Al-Hilli Z, Hoskin TL, Heins CN, Boughey JC.

Ann Surg Oncol. 2016 Oct;23(10):3206-11. doi: 10.1245/s10434-016-5324-y. Epub 2016 Jun 21.

PMID:
27328945
45.

Perceived dyscognition reported by patients with fibromyalgia.

McAllister SJ, Toussaint LL, Williams DA, Hoskin TL, Whipple MO, Vincent A.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S48-54. Epub 2016 Feb 26.

PMID:
26941074
46.

Natural history of age-related lobular involution and impact on breast cancer risk.

Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC.

Breast Cancer Res Treat. 2016 Feb;155(3):423-30. doi: 10.1007/s10549-016-3691-5. Epub 2016 Feb 4.

47.

Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.

Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC.

Surgery. 2016 Apr;159(4):1199-209. doi: 10.1016/j.surg.2015.11.001. Epub 2015 Dec 17.

PMID:
26704783
48.

Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease.

Al-Hilli Z, Hieken TJ, Hoskin TL, Heins CN, Boughey JC.

J Surg Oncol. 2015 Oct;112(5):453-7. doi: 10.1002/jso.24034. Epub 2015 Sep 8.

PMID:
26345596
49.

Patients With Fibromyalgia Have Significant Autonomic Symptoms But Modest Autonomic Dysfunction.

Vincent A, Whipple MO, Low PA, Joyner M, Hoskin TL.

PM R. 2016 May;8(5):425-35. doi: 10.1016/j.pmrj.2015.08.008. Epub 2015 Aug 24.

50.

ERβ expression and breast cancer risk prediction for women with atypias.

Hieken TJ, Carter JM, Hawse JR, Hoskin TL, Bois M, Frost M, Hartmann LC, Radisky DC, Visscher DW, Degnim AC.

Cancer Prev Res (Phila). 2015 Nov;8(11):1084-92. doi: 10.1158/1940-6207.CAPR-15-0198. Epub 2015 Aug 14.

Supplemental Content

Loading ...
Support Center